Summary
Demonstrate the effectiveness of LAA exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for artial fibrillation and ischemic stroke
Description
This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.
Principal Investigator
Hazaim Alwair
Study Coordinator
Kristi Sutphin
Faculty Contact
Kristi Sutphin - kristi.sutphin@vandaliahealth.org
Research Contact
CAMC Clinical Trials Center
304.388.9944
Departments
Sex
All
Age
18+
NCT Number
NCT05478304
IRB Number
25-1187